Clarity Pharmaceuticals (ASX:CU6) Is Up 27.3% After Completing Enrollment In Pivotal AMPLIFY Prostate Cancer Trial

Clarity Pharmaceuticals recently announced that its pivotal Phase III AMPLIFY trial of 64Cu-SAR-bisPSMA PET for recurrent prostate cancer has fully consented more than the planned 220 participants ...
inews.co.uk

I'm a urologist, eight changes I made in my 50s to cut my risk of cancer

Dr Marc Laniado made a choice to be more mindful of his own health - here's what he discovered, from 'exercise snacking' to ...
Earth.com

Frequent ejaculation is associated with lower risk of prostate cancer

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

We’re cancer doctors. These are the symptoms most people overlook

Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...